In women with hypothyroidism, levothyroxine (LT) requirements after deliver
y are assumed to return to prepregnancy values. The occasional observation
of discordances prompted this study. Forty-one women (31 receiving LT repla
cement therapy and 10 receiving suppressive therapy for thyroid carcinoma)
were followed during the first year after delivery. A control group of 31 n
onpregnant women with hypothyroidism (n = 21) or thyroid carcinoma (n = 10)
were also followed during a similar period. Twenty-three patients of 41 (5
6.1%) had discordant requirements at follow-up after delivery vs. 3 of 31 i
n the control group (9.7%; P < 0.001). The patterns of discordance in the p
ostdelivery group were hyperthyroidism in 12, increase in LT dose in 5, hyp
er- and hypothyroidism in 5, and recurrence of Graves' disease in 1 women.
Those in the control group were increase in LT dose, hyperthyroidism, and h
ypo- and hyperthyroidism. The rate of patients with discordant prepregnancy
-postpartum LT doses was higher in the noncarcinoma subgroup (61.7% vs. 20.
0%; P < 0.01), whereas in the control group, both subgroups displayed a sim
ilar rate of discordance (9.5% vs. 10%; P = NS). In conclusion, this study
documents that women with hypothyroidism antedating pregnancy display chang
es in LT requirements in the first year after delivery that suggest postpar
tum thyroiditis.